The ATP2A2 gene helps skin cells handle calcium, and if it does not work properly, the skin can become fragile and develop rough, scaly bumps and patches. This gene plays an important role in how skin cells stick together and mature. Pathogenic variants in the ATP2A2 gene cause Darier disease, an inherited skin condition that often affects the chest, back, scalp, and skin folds, and may also change the nails or mouth lining.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Others mainly help determine when, where, and how strongly certain processes take place. Taken together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
ATP2A2Gene function
What if the gene works
The ATP2A2 gene helps move calcium into storage spaces inside cells. This supports steady cell signaling and is especially important for healthy skin and normal heart and muscle function.
Risk
What if the gene does not work
Variants in the ATP2A2 gene most often cause Darier disease, a skin condition with rough, wart-like or crusted bumps in oily areas and changes in the nails. Effects can range from mild to more marked, depending on the variant.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to the ATP2A2 gene is currently established. Care is based on symptoms and severity, with standard skin treatments chosen clinically rather than by the ATP2A2 variant itself.
Conditions associated with ATP2A2
Genetic variants
What if the gene does not work
Variants in the ATP2A2 gene can make its calcium pump unstable, poorly folded, or less active, showing how ATP2A2 gene variants affect skin cells. This reduces calcium movement into a cell storage space, which weakens cell-to-cell adhesion and skin cell maturation. Some variants are milder and leave partial pump activity, while more disruptive variants can greatly reduce or abolish it. That range may influence how early Darier disease appears and how marked the skin changes are.
How variants are linked to conditions
Pathogenic variants in the ATP2A2 gene cause Darier disease, an inherited skin condition that often leads to rough, wart-like bumps in oily areas such as the chest, back, scalp, and forehead. Some ATP2A2 gene variants are also linked to acrokeratosis verruciformis of Hopf, which is now often viewed as part of the same clinical spectrum. These links are well established in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATP2A2, the chance of developing Darier disease is mostly set by the gene change itself, but symptoms can be made worse by heat, sweating, sun exposure, skin friction, and some medicines such as lithium. Stress and skin infections can also trigger flares or make them more noticeable.
Inheritance of ATP2A2 variants
ATP2A2-related skin conditions are usually inherited in an autosomal dominant pattern, which means a person only needs one altered copy of the ATP2A2 gene to be affected. If you carry a disease-causing ATP2A2 variant, each child has a 50% chance of inheriting it. Some people with an ATP2A2 variant are the first in their family to have it because the change began new in them. This ATP2A2 inheritance pattern is the one most often seen in families.
What does my ATP2A2 result mean for my family?
A disease-causing change in the ATP2A2 gene is usually passed down in a dominant pattern, so close relatives such as a parent, brother, sister, or child may also carry the same change and may want to learn whether it applies to them. In families with ATP2A2-related Darier disease, each child of an affected parent has a 50% chance of inheriting the gene change. Some cases happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find out about ATP2A2 variants, genetic testing for ATP2A2 variants uses a blood sample, saliva, or cheek swab to read the ATP2A2 gene's DNA code. This can show whether a variant is present and whether it matches a change linked with Darier disease. Results may help clarify a diagnosis and support family testing.
When should I consider getting a genetic test?
Consider genetic testing for the ATP2A2 gene if you or your child has a skin condition called Darier disease, with rough or crusty bumps in oily areas like the chest, back, scalp, or forehead, especially with nail changes. Testing can also be helpful when this condition runs in the family or when doctors want to confirm the cause.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the type of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it acts, or how sensitive your body is to its effects. This helps explain why the same treatment works well for one person, has less benefit for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect the way a person responds to medication. It focuses on the relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help guide treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the ATP2A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, new symptoms after starting a medicine, or how your treatments fit with your overall health, talk with your doctor or pharmacist.
History
The history of the ATP2A2 gene is closely tied to a skin condition long known to doctors as Darier disease, also called Darier-White disease. Throughout history, people have described features that hinted at this gene. In 1889, French dermatologist Ferdinand-Jean Darier and, separately, American dermatologist James Clarke White published the first clear medical descriptions of the condition. More than a century later, researchers mapped the inherited cause to chromosome 12, and in 1999 the ATP2A2 gene was identified as the gene involved. From these first observations, research expanded steadily, helping connect older clinical descriptions with modern genetic diagnosis.